The market size of the Global Pharmaceutical Plastic Bottles Market in the year 2019 is valued at 7.16 billion and is predicted to reach 11.44 billion by the year 2030 at a 5.6% CAGR during the forecast period.
Curious about this latest version of report? Obtain Report [email protected] https://www.insightaceanalytic.com/report/global-pharmaceutical-plastic-bottles-market/1284
The COVID-19 pandemic has resulted in an incremental expansion in the global healthcare industry. The healthcare industry’s growth has resulted in a higher demand for efficient and cost-effective pharmaceutical packaging solutions. Plastic bottles are commonly used in the pharmaceutical industry to package solid and liquid formulations. The demand for pharmaceutical plastic bottles is expected to rise in the coming years, owing to the global expansion of healthcare infrastructure. Traditionally, pharmaceutical glass bottles were widely used in the industry, however, with the arrival of plastic bottles to the market and their cost and weight advantages, the pharmaceutical bottle market has seen a significant transformation. Moreover, several technological developments in factors such as the type of plastic used, the diversity of closures supplied, and the vast range of sizes have positively impacted sales in the pharmaceutical plastic bottle market. Plastic bottles are increasingly being used in the industry for aseptic filling and packaging. Market vendors in various regions offer aseptic bottle filling and packaging services. For instance, LSNE provides aseptic dropper bottle filling. The company has an automated filling line that can fill standard multi-dose three-piece bottles in 5 ml and 10 ml sizes, as well as sterile multi-dose bottles.
List of Prominent Players in the Global Pharmaceutical Plastic Bottles Market:
Berry Global Inc.
West Pharmaceutical Services Inc.
For More Information @ https://www.insightaceanalytic.com/report/global-pharmaceutical-plastic-bottles-market/1284
The global expansion of the pharmaceutical industry, combined with rising demand for blister packaging, is expected to drive the pharmaceutical plastic bottle market forward. Besides this, the emergence of new innovative packaging technologies is a crucial factor that has the potential to cause the pharmaceutical plastic bottle market forward. Moreover, features of pharmaceutical plastic bottles, such as cost-effectiveness and lightness, can support the market growth. Key market players’ business growth strategies such as new product development, mergers, and acquisitions, among others, are predicted to deliver significant growth opportunities for the pharmaceutical plastic bottles market during the forecast period.
The prime challenge is the lack of in-house packaging capabilities, and budget constraints regarding plastic bottle products in developing countries predicted to reduce the growth of the global pharmaceutical plastic bottle market. Manufacturers are taking the support of government stimulus packages and making use of BFSI initiatives to stay financially afloat, owing to the challenges created by the pandemic. Clinical challenges are influencing the need for IV (intravenous) bottles, as IV therapy is related to issues including extravasation, which is an unintended condition in which the treatment is supplied outside of a vein. Moreover, the infusion piercing operation is a painful task for the patient. Rising environmental concerns over the use of plastics are also restricting factors limiting market expansion. The use of PET bottles is restricted by market regulations.
The North American pharmaceutical plastic bottles market is expected to register a major market share over the forecast period. The market for plastic bottles in the United States is predicted to grow significantly due to increased consumption and industrial uses of plastic-made containers and bottles. According to the Plastics Industry Association (PLASTICS), the market demand for plastic bottles is expanding in the United States. Plastic projects are expected to increase across a variety of products and industries, including beverage, food and water, pharmaceutical, and household. Besides, Asia Pacific had a notable share in the market owing to the strong presence of manufacturing industries. In addition, lower labor costs and easy availability of raw materials are expected to drive the growth of the region’s target market. China is also one of Asia’s largest pharmaceutical markets, making it lucrative for pharmaceutical plastic bottle manufacturers.
- In April 2022, Amcor has expanded its pharmaceutical packaging offering with new, more sustainable High Shield laminates. The new low carbon, recycle-ready packaging choices provide on two fronts: they meet the industry’s high barrier and performance criteria while also supporting pharmaceutical firms’ recyclability objectives.
- In March 2021, Gerresheimer AG, has begun construction and development of its new manufacturing facility in Ohio, United States. The facility will also be able to manufacture plastic bottles for solid, liquid, and ophthalmic/nasal formulations.
Segmentation of Global Pharmaceutical Plastic Bottles Market –
By Bottle Types –
- Plastic Bottles for Solid Formulation
- Plastic Bottles for Liquid
- Plastic Bottles for Ophthalmic/Nasal Formulation
By Material Types –
- Polyethylene (PE)
- High-density polyethylene (HDPE)
- Low-density polyethylene (LDPE)
- Polyethylene terephthalate (PET)
- Polypropylene (PP)
- Polyvinyl chloride (PVC)
By Capacity –
- Below 100 ml
- 100 ml – 250 ml
- Above 250 ml
By Region –
North America –
- The U.S.
- The U.K.
- Rest of Europe
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America –
- Rest of Latin America
Middle East & Africa –
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Request for ToC/Proposal: https://www.insightaceanalytic.com/request-sample/1284